FURIEX PHARMACEUTICALS
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The companyโs products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections.
FURIEX PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1998-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.furiex.com
Total Employee:
10001+
Status:
Active
Contact:
19194567850
Total Funding:
15 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Akamai Hosted MarkMonitor DNS
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Illumina Accelerator
Illumina Accelerator is a company creation engine focused on building breakthrough genomics startups!
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fred Eshelman
Fred Eshelman investment in Post-IPO Debt - Furiex Pharmaceuticals
Official Site Inspections
http://www.furiex.com
- Host name: redirection.constellix.com
- IP address: 208.80.123.197
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago